Ownership history in Qube Research & Technologies Ltd · 8 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in WEREWOLF THERAPEUTICS INC (HOWL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 29,250 | -15,011 | -33.9% | 0.00% | $58K | $1.97 |
| 2025 Q2 | ADDED | 44,261 | +35,946 | +432.3% | 0.00% | $48K | $1.09 |
| 2024 Q2 | REDUCED | 8,315 | -108,698 | -92.9% | 0.00% | $20K | $2.44 |
| 2024 Q1 | ADDED | 117,013 | +114,629 | +4808.3% | 0.00% | $758K | $6.48 |
| 2023 Q4 | ADDED | 2,384 | +2,382 | +119100.0% | 0.00% | $9K | $3.86 |
| 2023 Q3 | REDUCED | 2 | -19,906 | -100.0% | 0.00% | $4 | $2.14 |
| 2022 Q3 | REDUCED | 19,908 | -2,627 | -11.7% | 0.00% | $90K | $4.51 |
| 2022 Q2 | INITIATED | 22,535 | — | — | 0.00% | $92K | $4.09 |
As of 2025 Q4 — sorted by position size